Cargando...
JAK inhibitors and infections risk: focus on herpes zoster
Currently, there is a growing interest in Janus kinase (JAK) intracellular signalling since targeted inhibitors against these pathways are proving effective in the treatment of a range of immune-mediated diseases, such as rheumatoid arthritis (RA), psoriasis, psoriatic arthritis (PsA), inflammatory...
Guardado en:
| Publicado en: | Ther Adv Musculoskelet Dis |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7328488/ https://ncbi.nlm.nih.gov/pubmed/32655703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20936059 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|